Advertisement

NLS Biotech News

Biotech Business – February 11, 2025

Abera announces promising results

Abera Bioscience reports that its first in vivo study with a novel nasal influenza vaccine candidate has delivered promising results in the mouse model.

Biotech Business – February 5, 2025

Aqilion resumes development of its TAK1-program

The company has resumed development of the its TAK1 program as the company has regained the control and ownership of the program.

Biotech Business – February 4, 2025

Aplagon announces EUR 7 million financing

The funding round was led by new investors Fåhraeus Startup and Growth (FSG), a Nordic venture capital fund, and European Innovation Council (EIC) Fund.

Acquisition – January 31, 2025

WntResearch carries out a conditional reverse acquisition of OPSY

WntResearch has entered into an agreement for the acquisition of all shares in the Swedish privately owned company OPSY for a purchase price of approximately SEK 120 million, to be paid with newly issued shares in WntResearch.

Biotech Business – January 27, 2025

Oncopeptides’ Pepaxti formally approved for full reimbursement in Italy

The positive reimbursement decision for Pepaxti (melflufen) has been published in the Italian Official Journal.

Clinical trials

Profiles in Biotech

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.